Alireza Pouramini, M. Khosravian, Fatemeh Kafi, Sina Bakhshaei, H. Jahantigh, P. Peymani, N. Kianpour, M. Foroutan
{"title":"希望和恐惧;Paxlovid用于治疗COVID-19:致编辑的一封信","authors":"Alireza Pouramini, M. Khosravian, Fatemeh Kafi, Sina Bakhshaei, H. Jahantigh, P. Peymani, N. Kianpour, M. Foroutan","doi":"10.34172/npj.2022.10485","DOIUrl":null,"url":null,"abstract":"impairment. Additionally, Paxlovid requires Implication for health policy/practice/research/medical education: Paxlovid is an effective oral treatment for COVID-19 patients that reduces mortality and can be administered in an outpatient setting, but it cannot substitute COVID-19 immunizations.","PeriodicalId":16388,"journal":{"name":"Journal of Nephropharmacology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor\",\"authors\":\"Alireza Pouramini, M. Khosravian, Fatemeh Kafi, Sina Bakhshaei, H. Jahantigh, P. Peymani, N. Kianpour, M. Foroutan\",\"doi\":\"10.34172/npj.2022.10485\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"impairment. Additionally, Paxlovid requires Implication for health policy/practice/research/medical education: Paxlovid is an effective oral treatment for COVID-19 patients that reduces mortality and can be administered in an outpatient setting, but it cannot substitute COVID-19 immunizations.\",\"PeriodicalId\":16388,\"journal\":{\"name\":\"Journal of Nephropharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nephropharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/npj.2022.10485\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephropharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/npj.2022.10485","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor
impairment. Additionally, Paxlovid requires Implication for health policy/practice/research/medical education: Paxlovid is an effective oral treatment for COVID-19 patients that reduces mortality and can be administered in an outpatient setting, but it cannot substitute COVID-19 immunizations.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
